Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Asos CFO snaps up shares

(Sharecast News) - Asos revealed on Wednesday that chief financial officer Dave Murray had acquired 5,800 ordinary shares in the London-listed fashion retailer.

Murray, who was appointed to the role of CFO back in April, purchased the shares on Tuesday at an average price of 345.95p each, for a total value of £20,065.25.

As of 1600 GMT, Asos shares were down 2.11% at 344.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Spectris (SXS) Director name: Williamson,Mark Amount purchased: 12,116 @ 2,476.03p Value: £299,995.79

Bhp Group Limited Npv (di) (BHP) Director name: Lindsay,Don Amount purchased: 10,000 @ $42.79 Value: $226,486.00

Bhp Group Limited Npv (di) (BHP) Director name: Lindsay,Don Amount purchased: 10,000 @ $42.79 Value: $226,486.00

Spectris (SXS) Director name: Gradden,Mandy Amount purchased: 7,898 @ 2,506.62p Value: £197,972.74

Spectris (SXS) Director name: Noon,Angela Amount purchased: 1,650 @ 30.60 Value: 45,486.49

Alkemy Capital Investments (ALK) Director name: Atherley,Paul Campbell Amount purchased: 55,245 @ 72.00p Value: £39,776.40

Asos (ASC) Director name: Murray ,Dave Amount purchased: 5,800 @ 345.95p Value: £20,065.25

Personal Group Holdings (PGH) Director name: Constant,Paula Amount purchased: 9,998 @ 199.98p Value: £19,993.50

Mears Group (MER) Director name: Critchley,Lucas Amount purchased: 5,468 @ 363.00p Value: £19,848.84

Mears Group (MER) Director name: Critchley,Lucas Amount purchased: 4,518 @ 362.25p Value: £16,366.45

Alkemy Capital Investments (ALK) Director name: Atherley,Paul Campbell Amount purchased: 6,340 @ 83.00p Value: £5,262.20

Alkemy Capital Investments (ALK) Director name: Atherley,Paul Campbell Amount purchased: 5,000 @ 88.00p Value: £4,400.00

Alkemy Capital Investments (ALK) Director name: Atherley,Paul Campbell Amount purchased: 5,000 @ 83.00p Value: £4,150.00

Alkemy Capital Investments (ALK) Director name: Atherley,Paul Campbell Amount purchased: 5,000 @ 78.00p Value: £3,900.00

Alkemy Capital Investments (ALK) Director name: Atherley,Paul Campbell Amount purchased: 5,000 @ 76.00p Value: £3,800.00

Alkemy Capital Investments (ALK) Director name: Atherley,Paul Campbell Amount purchased: 4,000 @ 82.00p Value: £3,280.00

Top Director Sells

Smiths News (SNWS) Director name: Bunting,Jonathan Amount sold: 1,183,423 @ 60.56p Value: £716,680.97

Maxcyte (di) (MXCT) Director name: Erck ,Stan Amount sold: 47,689 @ $3.72 Value: $146,118.59

Alumasc Group (ALU) Director name: Leaf,Michael Amount sold: 8,370 @ 310.00p Value: £25,947.00

Aferian (AFRN) Director name: White,Sebastian Amount sold: 53,214 @ 5.25p Value: £2,793.73

Share this article

Related Sharecast Articles

Director dealings: Tracsis director snaps up shares
(Sharecast News) - Tracsis revealed on Wednesday that non-executive director Tracy Sheedy had acquired 950 ordinary shares in the AIM-listed transport software provider.
Director dealings: Admiral director raises stake
(Sharecast News) - Admiral Group revealed on Tuesday that non-executive director Justine Roberts had acquired 1,044 ordinary shares in the FTSE 100-listed insurer.
Director dealings: Creo Medical chairman raises stake
(Sharecast News) - Creo Medical revealed on Monday that chairman Kevin Crofton had acquired 1.17m ordinary shares in the London-listed medical device company.
Director dealings: Rentokil Initial director makes share purchase
(Sharecast News) - Rentokil Initial revealed on Friday that non-executive director Brian Baldwin had acquired 7.5m ordinary shares in the FTSE 100-listed pest control business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.